Active — Not RecruitingPhase 2

PONV Prevention Via Percutaneous Nerve Electrical Stimulation on PC6

China302 participantsStarted 2024-01-12

Plain-language summary

This study aims to certify the effectiveness of percutaneous electrical nerve stimulation at Pericardium 6 (PC6) via a wearable equipment during perioperative period on preventing postoperative nausea and vomiting.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients aged 18-65 years;
✓. Patients undergoing elective laparoscopic surgery;
✓. American Society of Anaesthesiologists(ASA) Grade 1 to 3;
✓. Anesthesia: General Anesthesia, Tracheal Intubation;
✓. BMI: ≥18, \<28;
✓. Gender: female
✓. Patients or their family members are able to comprehend the study protocol and are willing to participate in this research by providing written informed consent.

Exclusion criteria

✕. There are incisions or scars in the wearing position of the device;
✕. There is a local infection in the wearing position of the device;
✕. upper extremity nerve injury;
✕. history of spinal cord surgery;
✕. Participated in other clinical trials within 4 weeks;
✕. suffering from severe central nervous system disease or mental disorder;
✕. Patients need to return to the ICU after surgery.

What they're measuring

Incidence of postoperative nausea and vomiting(PONV)

Timeframe: 24 hours after surgery

Trial details

NCT IDNCT06241547

SponsorPeking Union Medical College Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-10

View on ClinicalTrials.gov More Postoperative Nausea and Vomiting trials